Keisuke Enomoto

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Cancer Stem Cells

Chronic Kidney Disease

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet Gunduz, Esra Gunduz, Shunji Tamagawa, Keisuke Enomoto, Muneki Hotomi
Cancer Stem Cells in Oropharyngeal Cancer. Cancers 13 (15) (2021)
Keisuke Enomoto, Shun Hirayama, Naoko Kumashiro, Xuefeng Jing, Takahito Kimura, Shunji Tamagawa, Ibu Matsuzaki, Shin-Ichi Murata, Muneki Hotomi
Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models. Cancers 13 (4) (2021)